Brazilian study tracks IBD drug use without new treatments
NCT ID NCT05626088
First seen Feb 26, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This study watches over 1,000 adults with ulcerative colitis or Crohn's disease in Brazil who are taking or have taken vedolizumab. Researchers are not giving any new treatment—they are just collecting information to see how long people stay on the drug and what other treatments they have used. The goal is to understand real-world use of vedolizumab for inflammatory bowel disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pesquisare Saúde S/S Ltda
Santo André, São Paulo, 09080-001, Brazil
Conditions
Explore the condition pages connected to this study.